Skip to main content
. Author manuscript; available in PMC: 2008 Sep 1.
Published in final edited form as: Am J Trop Med Hyg. 2007 Sep;77(3):458–463.

TABLE 2.

Comparative costs for malaria treatment of West African refugees by strategy, 1998–2004*

Strategy Artemether-lumefantrine presumptive treatment Observed U.S. malaria cases Expected U.S. malaria cases

Presumptive overseas Pre-departure treatment All Actual None
Refugees treated 2,332 51 191
Cost per treatment course $14.40 $1,729.50 $1,729.50
Total treatment cost $33,580 $88.205 $330,335
Relative treatment cost 38% 100% 375%
Malaria prevalence: cost-benefit policy breakpoint§ 1.0% NA NA
*

NA = not applicable.

Theoretical.

If overseas presumptive therapy had not started in 1999, an expected 191 cases of malaria would have occurred among 2,332 refugees. This is derived from the preimplementation refugee malaria rate of 8.2%.

§

Prevalence of malaria above which it is more cost-beneficial to use an overseas presumptive treatment strategy.